ClinicalTrials.gg

Program

lobeglitazone

Also written as “CKD-501 0.5mg”, “CKD-501” and “CKD-501, D745, D150”.

Its studies are mostly in Diabetes Mellitus, Type 2 · Renal Insufficiency · Liver Diseases, led by Chong Kun Dang Pharmaceutical.

Furthest: phase 3, since Oct 23, 200925 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chong Kun Dang Pharmaceutical250 open or runningphase 3since Oct 23, 2009Oct 23, 2009none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 6 studies since Oct 23, 2009.

  1. Apr 5, 20112 phase 1 studies in Diabetes Mellitus, Type 2NCT01330563, NCT01341392
  2. Nov 25, 2013Phase 1 study in Diabetes Mellitus, Type 2NCT02002611 · 24 enrolled · Korea, Republic of
  3. Dec 3, 20132 phase 1 studiesNCT02007941, NCT02005744
  4. Sep 23, 2015Phase 1 study in Diabetes Mellitus, Type 2NCT02565368 · 26 enrolled · Korea, Republic of
  5. Dec 21, 2015Phase 1 study in Diabetes Mellitus, Type 2NCT02648854 · 26 enrolled · Korea, Republic of
  6. Jun 30, 2016Phase 1 study in Diabetes Mellitus, Type 2NCT02824874 · 20 enrolled · Korea, Republic of
  7. Aug 1, 2016Phase 1 study in Diabetes Mellitus, Type 2NCT02854748 · 30 enrolled · Korea, Republic of
  8. Feb 22, 2018Phase 3 study in Type2 DiabetesNCT03739125 · 226 enrolled · Korea, Republic of
  9. Jul 4, 20182 phase 3 studies in Type2 DiabetesNCT03627182, NCT03641352
  10. Jul 8, 2018Phase 1 study in Diabetes Mellitus, Type 2NCT03616392 · 41 enrolled · Korea, Republic of
  11. Mar 31, 2020Phase 1 study in Diabetes Mellitus, Type 2NCT04334213 · 48 enrolled · Korea, Republic of
  12. Jun 11, 2020Phase 1 study in Diabetes Mellitus, Type 2NCT04431687 · 48 enrolled · Korea, Republic of
  13. Jan 10, 2021Phase 1 study in Diabetes Mellitus, Type 2NCT04706286 · 26 enrolled · Korea, Republic of
  14. Dec 14, 20253 phase 1 studies in Diabetes Mellitus, Type 2NCT07304726, NCT07304700, NCT07304687

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 25 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07304726Diabetes Mellitus, Type 2 · South Korea1CompletedNov 9, 202530
NCT07304700Diabetes Mellitus, Type 2 · South Korea1CompletedNov 7, 202530
NCT07304687Diabetes Mellitus, Type 2 · South Korea1CompletedNov 3, 202531
NCT04706286Diabetes Mellitus, Type 2 · Korea, Republic of1UNKNOWNMar 29, 202126
NCT04431687Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedJul 24, 202048
NCT04334213Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedAug 5, 202048
NCT03641352Type2 Diabetes · Korea, Republic of3UNKNOWNApr 30, 2021240
NCT03616392Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedSep 17, 201841
NCT03627182Type2 Diabetes · Korea, Republic of3UNKNOWNMar 29, 2022240
NCT03739125Type2 Diabetes · Korea, Republic of3CompletedMay 25, 2020226
NCT02854748Diabetes Mellitus, Type 2 · Korea, Republic of1UNKNOWNSep 201630
NCT02824874Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedApr 201620
NCT02648854Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedOct 201526
NCT02565368Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedAug 201526
NCT02005744Liver Diseases · Korea, Republic of1CompletedFeb 201626
NCT02007941Renal Insufficiency · Korea, Republic of1CompletedApr 201528
NCT02002611Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedFeb 201424
NCT01341392Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedAug 201125
NCT01330563Diabetes Mellitus, Type 2 · Korea, Republic of1CompletedJun 201124
NCT01133431Healthy Male Volunteer · Korea, Republic of1CompletedJun 201024
NCT01106131Diabetes Mellitus, Type 2 · Korea, Republic of3CompletedApr 2012253
NCT01071720Healthy1CompletedJun 201024
NCT01030679Diabetes Mellitus, Type 2 · Korea, Republic of2CompletedOct 2008214
NCT01005160Healthy Male Volunteers1CompletedDec 200924
NCT01001611Diabetes Mellitus, Type 2 · South Korea3CompletedJan 2012173

How it is read

Names in the registry

  • “CKD-501 0.5mg”, 6 entries
  • “CKD-501”, 5 entries
  • “CKD-501, D745, D150”, 3 entries
  • “CKD-501, D759, D150”, 2 entries
  • “CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.